OTC Markets OTCPK - Delayed Quote USD

BioGaia AB (publ) (BGLAF)

Compare
9.58
0.00
(0.00%)
At close: March 26 at 4:00:00 PM EDT
Advanced Chart
Loading Chart for BGLAF
  • Previous Close 0.00
  • Open 12.31
  • Bid 11.10 x 29200
  • Ask 11.67 x 21500
  • Day's Range 12.31 - 12.31
  • 52 Week Range 9.58 - 12.31
  • Volume 257
  • Avg. Volume 0
  • Market Cap (intraday) 1.17B
  • Beta (5Y Monthly) 0.71
  • PE Ratio (TTM) 29.94
  • EPS (TTM) 0.32
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield 0.18 (1.83%)
  • Ex-Dividend Date May 8, 2025
  • 1y Target Est --

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was incorrporated in 1990 and is based in Stockholm, Sweden.

www.biogaia.com

225

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

More about BioGaia AB (publ)

Recent News: BGLAF

View More
View More

Performance Overview: BGLAF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

BGLAF
0.00%
OMX Stockholm 30 Index (^OMX)
7.89%

1-Year Return

BGLAF
93.15%
OMX Stockholm 30 Index (^OMX)
9.30%

3-Year Return

BGLAF
112.24%
OMX Stockholm 30 Index (^OMX)
7.06%

5-Year Return

BGLAF
246.17%
OMX Stockholm 30 Index (^OMX)
62.84%

Compare To: BGLAF

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

BGLAF
BioGaia AB (publ)
9.58
0.00%
Mkt Cap 1.17B
Industry Drug Manufacturers—Specialty & Generic
HLUN-B.CO
H. Lundbeck A/S
30.32
-5.43%
Mkt Cap DKK 29.159B
Industry Drug Manufacturers—Specialty & Generic
TEVA
Teva Pharmaceutical Industries Limited
13.80
-7.07%
Mkt Cap 16.072B
Industry Drug Manufacturers—Specialty & Generic

Statistics: BGLAF

View More

Valuation Measures

Annual
As of 2/28/2025

  • Market Cap

    1.11B

  • Enterprise Value

    987.60M

  • Trailing P/E

    29.63

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.33

  • Price/Book (mrq)

    6.05

  • Enterprise Value/Revenue

    7.99

  • Enterprise Value/EBITDA

    21.08

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    24.70%

  • Return on Assets (ttm)

    13.18%

  • Return on Equity (ttm)

    18.72%

  • Revenue (ttm)

    1.42B

  • Net Income Avi to Common (ttm)

    351.39M

  • Diluted EPS (ttm)

    0.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.22B

  • Total Debt/Equity (mrq)

    1.71%

  • Levered Free Cash Flow (ttm)

    254.52M

View More

Research Analysis: BGLAF

View More
View More

Company Insights: BGLAF

Research Reports: BGLAF

View More
View More

People Also Watch

BIOGY BioGaia AB (publ)
10.40
0.00%
 
NHYKF Norsk Hydro ASA
5.72
0.00%
 
ADBMF Audioboom Group plc
22.70
0.00%
 
ASMXF ASM International NV
485.61
0.00%
 
ARRPY Aeroports de Paris SA
12.30
0.00%
 
ACNFF Acomo N.V.
23.27
+24.57%
 
FNNTF flatexDEGIRO AG
15.15
0.00%
 
TMSNY Temenos AG
74.58
-5.16%
 
MBLU Morris State Bancshares, Inc.
21.00
+0.72%
 
VARRY Vår Energi AS
6.25
-0.48%
 
CHLSY Chocoladefabriken Lindt & Sprüngli AG
14.07
+1.22%
 
AEOXF Aeroports de Paris SA
99.42
0.00%
 
ESBS ES Bancshares, Inc.
6.45
-0.77%
 
ALFVF Alfa Laval AB (publ)
45.00
0.00%
 
DTWHF Daetwyler Holding AG
120.00
0.00%
 
BANC-PF Banc of California, Inc.
24.15
-1.67%